Evidence map›Paper›PMID 34959702›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Bioactivity Potential of

Aleksandra Owczarek, Joanna Kołodziejczyk-Czepas, Paulina Marczuk, Julia Siwek, Katarzyna Wąsowicz, Monika Anna Olszewska

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Varivax (IBRO neuroscience reports · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Bioactive compounds isolated from the bark ofPhytochemistry letters · 2024
    Article
  11. Chemodiversity of Arctic PlantPlants (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aleksandra OwczarekDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0002-4449-0692
Joanna Kołodziejczyk-CzepasDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.ORCID 0000-0001-8849-1067
Paulina MarczukDepartment of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
Julia SiwekDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.
Katarzyna WąsowiczDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0003-4228-8447
Monika Anna OlszewskaDepartment of Pharmacognosy, Faculty of Pharmacy, Medical University of Lodz, 90-151 Lodz, Poland.ORCID 0000-0001-8468-1365
Medical University of Lodz · PLUniversity of Łódź · PL

Funding

Medical University of Lodz 503/3-022-01/503-31-001University of Łódź 506/1136
6 · The paper itself

Abstract

Horse chestnut (

Indexed as

Aesculus hippocastanumastragalinflavonoidshuman plasmakaempferol glycosides

Identifiers

PMID34959702
PMCPMC8706066
OpenAlexW4200143140

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.